Carregant...

An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States

INTRODUCTION: The treatment with tyrosine kinase inhibitors (TKIs) has drastically improved the outcome of chronic myeloid leukemia (CML) patients. This study was conducted to examine the risk of secondary cancers (SCs) in the CML patients who were diagnosed and treated in the TKI era in the United...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PeerJ
Autors principals: Kumar, Vivek, Garg, Mohit, Chaudhary, Neha, Chandra, Abhinav Binod
Format: Artigo
Idioma:Inglês
Publicat: PeerJ Inc. 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813591/
https://ncbi.nlm.nih.gov/pubmed/29456888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.4342
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!